DIN 02558262 — PIASKY 170 MG
PIASKY is a solution of Crovalimab marketed by HOFFMANN-LA ROCHE LIMITED. The full Crovalimab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02558262
- Brand name
- PIASKY
- Active ingredient
- Crovalimab
- Strength
- 170 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Complement C5 inhibitor (humanized monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.